Private Equity

With a new $300M fund, the Detroit PE firm hires three principals to accelerate its 'Fix and Build' strategy in lower middle-market manufacturing.

Argentine police used a powerful AI to solve a complex homicide in hours, showcasing a new era of digital policing and its profound implications.

Private equity firm Gryphon Investors acquires HRSoft, signaling a major push towards AI-driven solutions for managing complex global pay structures.

Omni Family of Services doubles its size by acquiring JusticeWorks, expanding to 10 states and bringing 600 new staff into its employee-ownership model.

The asset manager is one of only three firms to secure top-ten spots in Barron's rankings for 1, 5, and 10-year performance. We dissect their success.

EFESO Management Consultants targets the booming mining and metals sector, launching a new practice to help firms navigate supply chain shifts and ESG pressures.

Five years after their takeover, Wrexham's Hollywood owners are again rewriting the script, this time from the commentary booth. Here's what it means.

A new deal brings Nanox's low-radiation, cost-effective Nanox.ARC to orthopedic clinics, aiming to reshape point-of-care diagnostics in the region.

As Akebia heads to a major conference, investors watch its Vafseo launch, new rare disease pipeline, and path to profitability. Here's what's at stake.

With a new focus and fresh capital, Trigon Metals begins a key drilling campaign at its Addana project, betting on Moroccan silver to power the future.

The deal sees CPM and MW Components move to UK-based Rosebank Industries, marking a major exit for the private equity firm and a strategic US expansion.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

In its first year post-Comcast, Versant Media battles linear TV declines with a bold digital pivot, a new dividend, and a $1 billion stock buyback.

A significant order for critical Tomahawk missile parts sends Mobix Labs' stock soaring, highlighting the firm's key role in a surging defense market.

Amid a booming gene therapy market, Oxford Biomedica Solutions launches key investor events to showcase its strategy and secure its leadership position.

The private equity firm's carve-out of the world's largest coworking franchisor signals a major push to scale flexible workspaces for the hybrid era.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

Three investment heavyweights—BCI, Norges Bank, and Brookfield—have formed Northview Energy, a new firm set to scale de-risked renewable assets.

Esperion's $75M+ deal for Corstasis and its novel nasal diuretic, Enbumyst, targets a $4B market and a new era of at-home edema management.

MAIA Biotechnology secured a crucial $30M to advance its promising lung cancer drug, but the move sent its stock plunging amid investor fears of dilution.